Form S-1
Please identify Intel Corp. as the affiliate that will hold the Dividend Note that you will be repaying with some of the proceeds from this offering.
No reply letter found.
Given that you are a holding company, please include an organizational chart depicting the ownership structure of the company after the reorganization.
No reply letter found.
Please identify the directors who will serve as both directors of the company and in senior management roles at Intel.
No reply letter found.
We note the number of common shares to be outstanding immediately after this offering excludes shares of Class A common stock issuable upon vesting of restricted stock awards to be issued under your equity incentive plan in connection with the completion of the offering. Please clarify why these shares are excluded.Rest of the question
For example, disclose if they relate to grants already made that have not yet satisfied the time based vesting criteria or the new Mobileye plan to be established in connection with the IPO. If you will issue restricted stock awards in connection with the IPO, please revise to disclose the number of shares to be granted, an estimate of the expected expense and provide disclosure of such grants in your subsequent events footnote, if applicable, pursuant to ASC 855-10-50-2.
No reply letter found.
We note your presentation of pro forma balance sheet information to reflect the Dividend distribution and the issuance of the Dividend Note. Please tell us how you considered the need to present pro forma information for other actions to be taken in your reorganization.Rest of the question
For example, the Dividend Note appears to be interest bearing and you disclose that you will legally purchase the equity interests of Moovit from Intel and enter into an asset purchase agreement with Intel.
No reply letter found.
Please clarify why you have included disclosure of earnings per share. In this regard, we note you have not presented net loss per share in your audited financial statements because you did not operate as a separate legal entity with your own capital structure during the periods presented therein.Rest of the question
If you intend to present a pro forma measure of earnings per share, please revise to label this as pro forma and provide footnotes explaining the purpose of the pro forma presentation. If there is more than one item included, please reconcile the numerator and denominator of your earnings per share measure. Refer to Article 11-02(a)(1) of Regulation S-X.
No reply letter found.
Please expand this risk factor to discuss the uncertainties and challenges relating to your reliance on Intel for the fabrication of silicon-photonics used in your FMCW LiDAR. Discuss the material terms of any agreements with Intel regarding the fabrication, including the termination provisions. File the manufacturing agreements with
No reply letter found.
For your largest Tier 1 customers that accounted for 35%, 19%, and 17% of your revenue in 2021, please identify the customers, summarize the material terms of your material agreements with these customers, and tell us what consideration you have given to filing any material agreements you have with these customers.
No reply letter found.
You disclose that you believe your non-GAAP measures may be helpful to investors because they allow for greater transparency with respect to key metrics used by management in operating your business. Please revise your disclosure to more fully explain how your non-GAAP measures allow for transparency and why that is useful to investors.Rest of the question
Also, revise to identify and disclose the key metrics used by management, including those referenced in this disclosure. Refer to SEC Release No. 33-10751.
No reply letter found.
You state that you exclude amortization of your acquisition-related intangible assets as you believe such adjustment facilitates a useful evaluation of your current operating performance, a comparison to your past operating performance and provides investors with additional means to evaluate cost and expense trends.Rest of the question
Please further revise to clarify that while you are excluding the amortization expense related to acquired intangible assets, your non-GAAP measures include revenue generated, in part, by such intangible assets. Also, revise to further explain why presenting non-GAAP measures of gross profit and margins excluding such costs is useful to investors.
No reply letter found.
Please tell us, and revise to clearly explain, how you determine the income tax effects for your measure of adjusted net income. Refer to Question 102.11 of the Non-GAAP Compliance and Disclosure Interpretations.
No reply letter found.
Throughout your results of operations, you attribute a portion of the change in various operating expenses to increases in headcount. Please revise to quantify the comparative headcount information to support the fluctuations in the impacted expenses. Refer to Item 303(b) of Regulation S-K.
No reply letter found.
Please tell us which reporting unit you performed a quantitative impairment test for during fiscal 2021 and the amount of goodwill allocated to such unit. Also, revise here to disclose whether your reporting unit is at risk of failing the quantitative impairment test or that the fair value of your reporting unit is substantially in excess of carrying value and is not at risk of failing.Rest of the question
If your reporting unit is at risk of failing, you should disclose: • the percentage by which fair value exceeded carrying value at the date of the most recent test; • the amount of goodwill allocated to the reporting unit; • a more detailed description of the methods and key assumptions used and how the key assumptions were determined; • a discussion of the degree of uncertainty associated with the assumptions; and • a description of potential events and/or changes in circumstances that could reasonably be expected to negatively affect the key assumptions.
No reply letter found.
Please tell us, and revise to disclose if material, the percentage of revenue derived from each of your commercially deployed solutions. Refer to Item 101(c) of Regulation S-K. Regulation and Ratings, page 97
No reply letter found.
You state that the patchwork of U.S. state restrictions on autonomous vehicles increases the legal complexity of deploying your solutions. If material, please discuss the short and long term plans you have made, if any, to navigate these restrictions and the extent to which failure to liberalize current regulations would have a significant impact on the demand for your solutions.
No reply letter found.
Please disclose whether you have an agreement with Intel regarding the composition of your board of directors, aside from Intel's control of a majority of voting power. Also, discuss the material terms of the Stockholders Agreement between the company and Intel that you intend to file as an exhibit.
No reply letter found.
We note that three customers comprise 35%, 19% and 17% of your revenue. Please tell us whether you have similar concentrations present in your accounts receivable balance. If so, revise to include a discussion of concentration of credit risk separately for each customer pursuant to ASC 275-10-50-18(a).
No reply letter found.
Please provide us with supplemental copies of all written communications, as defined in Rule 405 under the Securities Act, that you, or anyone authorized to do so on your behalf, have presented or expect to present to potential investors in reliance on Section 5(d) of the Securities Act, whether or not you retained, or intend to retain, copies of those communications.
No reply letter found.
We note your response to prior comment 8 that the Company does not believe the identity of its largest Tier 1 customers is material to an understanding of its business taken as a whole or necessary for investors to make an informed decision.Rest of the question
Given that each of your three largest customers have historically generated a material portion of your revenue and the company does not have long-term written agreements with those customers, the identity of the customers appears to be material information necessary for investors to understand the scope of the risk in the event that the customers discontinue or are unable to continue their relationship with the company. Please identify the customers and revise the risk factor to disclose that the company has not entered into written agreements with the customers but rather provides its products to such customers pursuant to standard purchase orders. Disclose also that the purchase orders and terms and conditions do not require your largest Tier 1 customers to purchase your solutions in any quantity or at a certain price.
No reply letter found.
You state that the sanctions and export controls imposed on Russia may contribute to higher oil and gas prices and inflation, which could reduce demand for your solutions. Please further disclose whether and how your business segments, products, lines of service, projects, or operations are materially impacted by supply chain disruptions in light of the conflict between Russia and Ukraine, specifically regarding theRest of the question
semiconductors needed for your EyeQ ® SoCs.
No reply letter found.
Please tell us how you considered whether any of the various agreements disclosed on pages 133-134 required pro forma adjustments to reflect the operations and financial position of Mobileye as an autonomous entity. Refer to Item 11-01(a)(7) and 1102(a)(6)(ii)of Regulation S-X.
No reply letter found.
To avoid giving undue prominence to your non-GAAP financial measures, please move this section so both the measures and your discussion of changes in, and future expected trends for, these measures follow the GAAP results of operations discussion. Refer to Item 10(e)(1)(i)(A) of Regulation S-K and Question 102.10 of the non-GAAP Compliance and Disclosure Interpretations.
No reply letter found.
Please tell us whether you intend to file the employment agreement with each of your named executive officers pursuant to Item 601(b)(10)(iii)(A) of Regulation S-K.
No reply letter found.
Please disclose that you have entered into certain arrangements with Intel under the Master Transaction Agreement and under your amended and restated certificate of incorporation that provide Intel with certain rights so long as Intel holds at least 20% of your common stock.Rest of the question
Describe the corporate actions that would require the prior consent of Intel, including but not limited to, the authorization of stock issuances. Risk Factors, page 19
No reply letter found.
Please add a risk factor disclosing that your amended and restated certificate of incorporation waived the corporate opportunities doctrine and address any potential conflicts of interest.
No reply letter found.
Please revise here to include a discussion of the minimum cash requirement provided by the terms of the Master Transaction Agreement that Intel has agreed to ensure you will have in cash, cash equivalents and marketable securities immediately after completion of the offering.
No reply letter found.
We note your discussion regarding the significant reduction in inventory levels due to your sole suppliers inability to meet your EyeQ SoC demands. Please revise your MD&A Overview section to discuss known trends or uncertainties resulting from these inventory shortages and mitigation efforts undertaken, if any.Rest of the question
Also, revise to specify whether these challenges have materially impacted your results of operations or capital resources and quantify, to the extent possible, how your sales, profits, and/or liquidity have been impacted.
No reply letter found.
Please revise here to include a quantified discussion regarding the impact from having an additional week in fiscal 2022 compared to 2021. Similarly, revise the Prospectus Summary and MD&A Overview disclosures where you discuss the 4.5% period-overperiod revenue growth to clarify how the additional week impacted your fiscal 2022 revenues.
No reply letter found.
In addition, you indicate that the increase in revenue during the first quarter of fiscal 2022 was due mainly to the sales of your SuperVision Solutions, which have a greater average price per vehicle compared to other ADAS. Please revise to include a quantified discussion regarding the impact of both changes in volume and price on your interim period results. Refer to Item 303(b)(2)(iii) of Regulation S-K.
No reply letter found.
You state that during the first half of 2022, you shipped approximately 16 million SoCs. Considering the significance of SoCs to your total revenue, coupled with the supply constraints related to chips, please revise throughout the filing to also disclose the number of SoC's shipped for each period presented to add context to this disclosure.
No reply letter found.
Please revise to highlight the key provisions relating to your ongoing relationship with Intel pursuant to the Master Transaction Agreement, including the material terms of any agreements related to the conduct of this offering and future transactions.Rest of the question
Disclose that you will grant Intel a continuing right to purchase from the company such number of shares of Class A common stock or Class B common stock as is necessary for Intel to maintain an aggregate ownership of your common stock representing at least 80.1% of your common stock outstanding following the completion of this offering. Also disclose that the Master Transaction Agreement provides that you will cooperate with Intel to accomplish a distribution by Intel of your common stock to Intel stockholders and that Intel will determine, in its sole and absolute discretion, whether to proceed with all or part of the distribution, the date of the distribution and the form, structure and all other terms of any transaction to effect the distribution, if at all.
No reply letter found.
We note that you removed the pro forma adjustment for the settlement of the related party loan in connection with the legal purchase of Moovit entities. Your disclosures on page F-48 indicate that the $900 million is payable in cash to Intel and presented within related party payable. Please clarify whether final settlement has been paid. If not, tell us how and when such amount will be settled.Rest of the question
To the extent final settlement relates to either the Reorganization or Offering transactions, revise as necessary to reflect this transaction in your pro forma financial statements or explain.
No reply letter found.
Your discussion appears to attribute the decrease in gross margin for the first half of fiscal 2022 to the sale of SuperVision with greater hardware content. On page 23 and 73 you indicate that as a result of the global semiconductor shortage and inflationary pressures, you have experienced, continue to experience and expect to experience in 2023, increases in the cost of your EyeQ SoCs.Rest of the question
You further state that while you are seeking to adjust prices charged to your customers, you anticipate your gross margin will decrease, as least in the short term. Please tell us, and revise your disclosures as necessary, to clarify how the semiconductor shortage and inflationary pressures impacted your gross margins for the first half of fiscal 2022.
No reply letter found.
We note your disclosure that, under the Technology and Services Arrangement and the LiDAR Product Collaboration Agreement, Intel will own most or all intellectual property that you develop involving lidar or radar technology. Please discuss the risks and uncertainties regarding how these arrangements may impact your business operations or financial results.Rest of the question
Disclose in the prospectus summary the risks and conflicts of interest related to your agreements with Intel.
The Company respectfully acknowledges the Staff’s comment and has revised the disclosure on pages 11, 12, 17, 51 and 52 to discuss the risks and uncertainties regarding how the arrangements under the Technology and Services Arrangement and the LiDAR Product Collaboration Agreement may impact the Company’s business operations or financial results and to disclose in the prospectus summary the risks and conflicts of interest related to theRead in the reply
Company’s agreements with Intel.
Please file as an exhibit the Cross-License Agreement. Refer to Item 601(b)(10) of Regulation S-K.
The Company respectfully acknowledges the Staff’s comment and has revised the disclosure on page 159 to clarify that the Cross-License Agreement was previously filed as Exhibit 10.21 to the Registration Statement.Read in the reply